Trials / Completed
CompletedNCT00652444
Effect Of Ezetimibe Coadministration With Simvastatin In A Middle Eastern Population: A Prospective, Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial (0653-151)
Effect Of Ezetimibe Coadministration With Simvastatin In A Middle Eastern Population: A Prospective, Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The primary outcome was percentage reduction of LDL-C after 6 weeks of randomization.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ezetimibe | ezetimibe 10mg. Blood samples were collected again at the end of study treatment, week 6. |
| DRUG | simvastatin | simvastatin 20mg . Blood samples were collected again at the end of study treatment, week 6. |
| DRUG | Placebo (Unspecified) | Matching ezetimibe placebo |
Timeline
- Start date
- 2003-09-01
- Primary completion
- 2004-08-01
- Completion
- 2004-08-01
- First posted
- 2008-04-03
- Last updated
- 2022-02-18
Source: ClinicalTrials.gov record NCT00652444. Inclusion in this directory is not an endorsement.